Animal studyindependent cross-checkabstract checked I-CHK-110 standard review

An antibiotic feed additive increased woody breast in a trial

Bacitracin, Bacillus subtilis, and Eimeria spp. challenge exacerbates woody breast incidence and severity in broilers.

Overview

Jia L et al.. Poult Sci 2022 · PMID 34788711 · DOI 10.1016/j.psj.2021.101512

Bacitracin, a probiotic and a parasite challenge each increased woody breast in some conditions.

Does the study support the specific claim? Partly · Methodological quality: low

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Do management factors (antibiotic, probiotic, coccidial challenge) affect WB incidence?

How was the study done?

Randomised factorial feeding trial in broilers (3 diets x cocci challenge x sex)

How many people, animals or samples were studied?

not stated in abstract

What was actually found?

Cocci challenge increased WB incidence on d 29 and d 43. Bacitracin increased early growth rate (d 0-14). In unchallenged birds, both the antibiotic and the probiotic diets increased WB incidence on d 43 (P = 0.040). Males had higher WB incidence.

How large was the observed effect?

Cocci challenge increased WB incidence on d 29 and d 43. Bacitracin increased early growth rate (d 0-14). In unchallenged birds, both the antibiotic and the probiotic diets increased WB incidence on d 43 (P = 0.040). Males had higher WB incidence.

What do the results mean in everyday life?

Things that push growth can make woody breast more common.

What are the study's limitations?

Sample size not in abstract; WB assessed by palpation; Probiotic had a similar effect, so the link is not antibiotic-specific

What does it say about Elawady's specific claim?

Gives partial support to an antibiotic role, but via growth, not as a specific cause.

Do the results apply to Germany and Europe?

EU bans antibiotic growth promoters; finding has limited relevance for legal EU production.

What can explicitly not be concluded from this study?

Cannot show that antibiotics are the main cause in practice.

Scientific in-depth review

1. Full reference

Authors
Jia L et al.
Journal
Poult Sci
Year
2022
Identifier
PMID 34788711 DOI 10.1016/j.psj.2021.101512
Verification
verified – PubMed efetch 2026-10-26; Crossref 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Do management factors (antibiotic, probiotic, coccidial challenge) affect WB incidence?

3. Study design and population

Study design
Animal study – Randomised factorial feeding trial in broilers (3 diets x cocci challenge x sex)
Population

Ross x Ross 708 broiler chicks

Country

USA

Period

not stated

Sample size

not stated in abstract

Inclusion and exclusion criteria

as described in the abstract

4. Methods and endpoints

Exposure / intervention

Bacitracin 6.075 mg/kg feed; Bacillus subtilis probiotic; live cocci vaccine challenge

Comparator

Basal diet without additives

Endpoints

Growth, WB incidence by palpation

Statistical methods

as reported in the abstract

5. Actual results

Results

Cocci challenge increased WB incidence on d 29 and d 43. Bacitracin increased early growth rate (d 0-14). In unchallenged birds, both the antibiotic and the probiotic diets increased WB incidence on d 43 (P = 0.040). Males had higher WB incidence.

Absolute risks

not reported

Authors' conclusion

Bacitracin and Eimeria spp. increased WB incidence, body weight and growth rate.

6. Strengths

  • Randomised design

7. Weaknesses

  • Sample size not in abstract
  • WB assessed by palpation
  • Probiotic had a similar effect, so the link is not antibiotic-specific

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Animal trial; abstract only.

9. Assessment of the statistical interpretation

Suggests that growth-promoting interventions in general (not only antibiotics) can increase WB.

10. Relevance to the specific claim

Only located trial linking an antibiotic growth promoter to woody breast.

11. Independent contrary findings

12. Transferability to Germany and Europe

13. Overall methodological judgement

Bacitracin, a probiotic and a parasite challenge each increased woody breast in some conditions.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitylow
Risk of biassome concerns
Precision of resultslow
Directnessindirect
Reproducibilitynot replicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks